Latest News for CLPBF
Please see enclosed pdf. Update to Financial Calendar Dates Coloplast has updated the dates in its financial calendar for the publication of the FY Financial Statements 2025/26 and the Annual General Meeting 2026.
Coloplast A/S (CLPBY) Q1 2026 Earnings Call Transcript
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact from currencies.
2025/26Interim financial results, Q1 2025/261 October 2025 - 31 December 2025 Coloplast delivered Q1 organic growth of 6% and EBIT growth1 in constant currencies of 3%. Reported revenue in DKK grew 0%, reflecting 4%-points negative impact from currencies.
Today, Coloplast is announcing changes to the company's Executive Leadership Team (ELT). The changes relate to the company's Interventional Urology business as well as the global People & Culture function.
🧮 Earnings Move Analyzer
Insider Trading
No insider trades found for CLPBF.
Senate Trading
No Senate trades found for CLPBF.
U.S. House Trading
No House trades found for CLPBF.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.